Moreover, the significance of changes in SOD2 amounts, as a suitable biomarker in the context of the mitochondrial signature in AD, has been further confirmed by the ultra-deep proteomic analysis of brain tissue and biofluids [28,29]. Here, SOD2 is linked to Alzheimer disease.